ERBB2 and cancer: According to Kaplan-Meier plotter, we found that a higher FHIT mRNA expression was negatively correlated with overall and progression-free survival rates of all cancer patients, even stratified by gender and Her2 status (Figure 4 and Table 2, p < 0.05).